Alcohol Intoxication
Alcohol intoxication is one of the most common emergency presentations. Management involves ABCDE assessment, excluding co-existing pathology, treating complications, and addressing alcohol use disorder on discharge.
Key Facts
Alcohol-related ED attendances account for approximately 12-15% of all presentations to UK emergency departments Blood alcohol level >400mg/dL (87 mmol/L) can be fatal; however, chronic drinkers may tolerate very high levels Key differential diagnoses to exclude: Head injury (intoxicated patients fall), hypoglycaemia, hepatic encephalopathy, Wernicke's encephalopathy, sepsis, overdose Wernicke's encephalopathy triad: Confusion, ataxia, ophthalmoplegia — treat with IV Pabrinex (thiamine) BEFORE glucose Pabrinex prophylaxis: IV pairs 1+2 TDS for 3-5 days if malnourished, chronic alcohol, suspected deficiency Alcohol withdrawal can be life-threatening — onset 6-24h; peak 24-72h; delirium tremens at 48-72h (mortality ~5%) CIWA-Ar score guides chlordiazepoxide dosing for alcohol withdrawal Always check blood glucose, consider head injury, and assess for concurrent drug ingestion in intoxicated patients
Overview
Key Facts
Alcohol intoxication and its complications represent a major burden on UK emergency services. The key challenge is not managing intoxication itself but identifying and treating co-existing or mimicking conditions that may be masked by alcohol.
Epidemiology
Alcohol-related hospital admissions in England exceed 1 million per year. ED attendances related to alcohol account for approximately 12-15% of all presentations (higher at weekends and overnight). Alcohol-related deaths in the UK: approximately 10,000 per year. Alcohol misuse costs the NHS approximately £3.5 billion annually.
Aetiology
- Acute intoxication: Binge drinking, chronic heavy drinking
- Alcohol use disorder: Affects approximately 6% of adults in England
- High-risk groups: Young adults (binge drinking), homeless populations, those with mental health comorbidity
Pathophysiology
Ethanol is a CNS depressant acting primarily via GABA-A receptor potentiation and NMDA receptor inhibition. It causes dose-dependent sedation, impaired coordination, slurred speech, and at high doses, respiratory depression and coma. Chronic use leads to neuroadaptation (GABA downregulation, NMDA upregulation), explaining tolerance and the potentially life-threatening withdrawal syndrome when alcohol is ceased.
Clinical Presentation
Stages of Intoxication
- Mild (50-150mg/dL): Disinhibition, impaired judgement, slurred speech
- Moderate (150-250mg/dL): Ataxia, dysarthria, emotional lability, nausea/vomiting
- Severe (250-400mg/dL): Stupor, marked ataxia, hypothermia, risk of aspiration
- Potentially fatal (>400mg/dL): Coma, respiratory depression, cardiovascular collapse
Red Flags
- Reduced GCS not proportionate to estimated alcohol intake — consider head injury, co-ingestion, metabolic cause
- Focal neurological signs — CT head to exclude intracranial pathology
- Hypoglycaemia — common in chronic drinkers and malnourished patients
- Hypothermia — particularly outdoor exposure while intoxicated
- Persistent vomiting — risk of Mallory-Weiss tear, aspiration, Boerhaave syndrome
- Confusion disproportionate to alcohol level — Wernicke's encephalopathy
Differential Diagnosis
| Diagnosis | Key Features | Investigation |
|---|---|---|
| Alcohol intoxication | History, smell, clinical features | Blood alcohol, clinical |
| Head injury | Fall, external signs, focal neurology | CT head |
| Hypoglycaemia | Sweating, tremor, confusion | Blood glucose |
| Wernicke's encephalopathy | Confusion, ataxia, ophthalmoplegia | Clinical (treat empirically) |
| Hepatic encephalopathy | Chronic liver disease, asterixis | Ammonia, clinical |
| Drug co-ingestion | Variable features | Drug screen, paracetamol level |
| Diabetic ketoacidosis | Kussmaul breathing, ketotic breath | Glucose, ketones, ABG |
| Methanol/ethylene glycol | Visual disturbance, severe acidosis, osmolal gap | ABG, osmolality |
Diagnosis / Investigation
Bedside
- ABCDE assessment: Airway protection is priority
- Blood glucose: Immediately — treat hypoglycaemia
- GCS: Serial monitoring — should improve over time; if not, investigate further
- Temperature: Hypothermia risk
- ECG: Arrhythmias (holiday heart syndrome — AF)
Bloods
- Blood alcohol level: Confirms intoxication; correlate with clinical state
- Blood glucose: Hypoglycaemia (impaired gluconeogenesis)
- U&Es: Electrolyte disturbance (hyponatraemia, hypokalaemia, hypomagnesaemia)
- LFTs: Acute/chronic liver damage
- FBC: Macrocytosis (chronic alcohol use), thrombocytopenia
- Paracetamol level: Always check for co-ingestion
- VBG/ABG: Lactate, pH, ketones
- Amylase/lipase: If abdominal pain (pancreatitis)
Imaging
- CT head: If head injury suspected, focal neurology, GCS not improving, anticoagulated
Special Tests
- AUDIT score: Alcohol Use Disorders Identification Test — screen before discharge
- Serum magnesium: Often low in chronic alcohol use
Management
Non-pharmacological
- Airway protection: Recovery position if unable to maintain airway; intubation if GCS ≤8 with no improvement
- Observation: Safe, monitored environment; serial GCS
- Rehydration: IV fluids (0.9% NaCl or Hartmann's) if dehydrated
- Warming: If hypothermic
- Brief intervention: For hazardous/harmful drinking — evidence-based approach at discharge
Pharmacological
- IV glucose: 100mL 20% glucose if hypoglycaemic — but give IV Pabrinex FIRST if Wernicke's suspected
- IV Pabrinex (high-potency B vitamins including thiamine): Pairs 1+2 TDS for 3-5 days if malnourished, suspected Wernicke's, or chronic alcohol use — BEFORE glucose administration
- Antiemetics: Ondansetron 4mg IV if significant vomiting
- Alcohol withdrawal management (if developing):
- Chlordiazepoxide reducing regimen (e.g., 30mg QDS day 1, reducing over 5-7 days) — guided by CIWA-Ar score
- Symptom-triggered dosing is safer than fixed-dose regimens
- Pabrinex throughout withdrawal period
Surgical/Interventional
- Not usually required; manage complications as they arise
Referral Criteria
- AUDIT score ≥8: Brief intervention; ≥16: Referral to alcohol services
- Dependent drinking: Alcohol liaison nurse, community alcohol team
- Recurrent presentations: Safeguarding, social services, dual diagnosis team if mental health comorbidity
- All deliberate self-harm with alcohol: Psychiatric assessment
Prognosis
- Acute intoxication: Self-limiting if uncomplicated; death from aspiration, respiratory depression, or hypothermia is preventable
- Alcohol-related liver disease: Leading cause of liver disease in the UK; ~6,000 deaths/year
- Alcohol withdrawal: Mortality from delirium tremens ~5% if untreated, <1% with treatment
- Brief interventions: NNT 8 to reduce hazardous drinking by 1 person
- Wernicke's encephalopathy: If untreated → 80% develop Korsakoff's syndrome (irreversible amnesia)
Other Relevant Information
CIWA-Ar Score Components
| Domain | Assessment |
|---|---|
| Nausea/vomiting | Severity 0-7 |
| Tremor | Severity 0-7 |
| Anxiety | Severity 0-7 |
| Agitation | Severity 0-7 |
| Paroxysmal sweats | Severity 0-7 |
| Orientation | Severity 0-4 |
| Tactile disturbances | Severity 0-7 |
| Auditory disturbances | Severity 0-7 |
| Visual disturbances | Severity 0-7 |
| Headache | Severity 0-7 |
Score >8: Treat; >15: Moderate withdrawal; >20: Severe withdrawal.
Alcohol Withdrawal Timeline
| Time After Last Drink | Features |
|---|---|
| 6-12 hours | Tremor, anxiety, sweating, tachycardia |
| 12-24 hours | Alcoholic hallucinosis (visual/auditory) |
| 24-48 hours | Withdrawal seizures (generalised tonic-clonic) |
| 48-72 hours | Delirium tremens (confusion, hallucinations, autonomic instability) |